|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0640 AUD | -3.03% |
|
0.00% | +4.92% |
| 05-13 | Control Bionics Limited Announces Board Changes, Effective May 14, 2026 | CI |
| 03-25 | Control Bionics announces first U.S. letter of intent for iOS speech device program | RE |
Company Valuation: Control Bionics Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Market Cap 1 | 58.04 | 19.56 | 7.872 | 10.36 | 8.838 |
| Change | - | -66.31% | -59.75% | 31.65% | -14.71% |
| Enterprise Value (EV) 1 | 45.71 | 14.57 | 7.008 | 10.27 | 8.601 |
| Change | - | -68.13% | -51.9% | 46.48% | -16.22% |
| P/E | -12.3x | -3.15x | -1.39x | -1.4x | -1.3x |
| PBR | 3.38x | 1.64x | 1.1x | 1.65x | 1.6x |
| PEG | 0.3x | -0.1x | 0.1x | 0x | 0x |
| Capitalization / Revenue | 14.2x | 4.06x | 1.4x | 1.94x | 1.44x |
| EV / Revenue | 11.2x | 3.03x | 1.24x | 1.92x | 1.4x |
| EV / EBITDA | -15.3x | -2.55x | -1.44x | -1.99x | -1.67x |
| EV / EBIT | -14.5x | -2.37x | -1.34x | -1.75x | -1.44x |
| EV / FCF | -25x | -2.71x | -2.74x | -3.86x | -3.52x |
| FCF Yield | -4% | -36.9% | -36.5% | -25.9% | -28.4% |
| Dividend per Share 2 | - | - | - | - | - |
| Rate of return | - | - | - | - | - |
| EPS 2 | -0.0566 | -0.0715 | -0.0624 | -0.0371 | -0.0231 |
| Distribution rate | - | - | - | - | - |
| Net sales 1 | 4.088 | 4.815 | 5.642 | 5.351 | 6.145 |
| EBITDA 1 | -2.996 | -5.722 | -4.87 | -5.158 | -5.139 |
| EBIT 1 | -3.149 | -6.139 | -5.235 | -5.882 | -5.957 |
| Net income 1 | -3.551 | -6.101 | -5.631 | -5.914 | -6.109 |
| Net Debt 1 | -12.33 | -4.985 | -0.8632 | -0.0969 | -0.2373 |
| Reference price 2 | 0.6950 | 0.2250 | 0.0870 | 0.0520 | 0.0300 |
| Nbr of stocks (in thousands) | 83,514 | 86,911 | 90,479 | 199,287 | 294,611 |
| Announcement Date | 8/25/21 | 8/24/22 | 8/30/23 | 8/27/24 | 9/12/25 |
1AUD in Million2AUD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 20.6M | |
| 60.28x | 4.66x | 15.61x | 0.35% | 15.89B | |
| 39.49x | - | - | 2.05% | 1.7B | |
| -10.36x | 1.29x | 5.68x | -.--% | 1.13B | |
| 16.65x | 2.36x | 7.9x | 1.41% | 998M | |
| 52.6x | - | - | 0.85% | 538M | |
| 47.61x | - | - | - | 467M | |
| 18.25x | 2.57x | 10.98x | 1.87% | 377M | |
| 23.94x | 4.25x | 13.94x | 1.85% | 371M | |
| Average | 31.06x | 3.03x | 10.82x | 1.2% | 2.39B | |
| Weighted average by Cap. | 51.06x | 4.28x | 14.48x | 0.59% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CBL Stock
- Valuation Control Bionics Limited
Select your edition
All financial news and data tailored to specific country editions
